International Assets Investment Management LLC Boosts Stock Holdings in UiPath Inc. (NYSE:PATH)

International Assets Investment Management LLC lifted its stake in UiPath Inc. (NYSE:PATH) by 1,649.1% during the 4th quarter, Holdings Channel reports. The institutional investor owned 177,358 shares of the healthcare company’s stock after buying an additional 167,218 shares during the period. International Assets Investment Management LLC’s holdings in UiPath were worth $4,406,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of PATH. Bleakley Financial Group LLC increased its stake in UiPath by 4.9% in the 4th quarter. Bleakley Financial Group LLC now owns 12,691 shares of the healthcare company’s stock worth $315,000 after purchasing an additional 598 shares during the period. 180 Wealth Advisors LLC raised its holdings in UiPath by 0.3% during the 4th quarter. 180 Wealth Advisors LLC now owns 188,950 shares of the healthcare company’s stock valued at $4,497,000 after buying an additional 492 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in UiPath by 2.3% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,301,413 shares of the healthcare company’s stock valued at $131,687,000 after buying an additional 119,782 shares during the period. Sowell Financial Services LLC increased its position in shares of UiPath by 116.1% in the fourth quarter. Sowell Financial Services LLC now owns 33,903 shares of the healthcare company’s stock valued at $842,000 after acquiring an additional 18,213 shares during the period. Finally, Arizona State Retirement System raised its stake in shares of UiPath by 8.7% during the fourth quarter. Arizona State Retirement System now owns 106,481 shares of the healthcare company’s stock valued at $2,645,000 after acquiring an additional 8,530 shares during the last quarter. Institutional investors own 62.50% of the company’s stock.

Analyst Upgrades and Downgrades

PATH has been the topic of several recent analyst reports. KeyCorp began coverage on UiPath in a research note on Monday, April 8th. They issued an “overweight” rating and a $27.00 target price on the stock. Truist Financial restated a “buy” rating and set a $32.00 target price on shares of UiPath in a report on Wednesday, March 20th. Mizuho lifted their price target on shares of UiPath from $22.00 to $25.00 and gave the company a “neutral” rating in a report on Thursday, March 14th. Canaccord Genuity Group boosted their price objective on shares of UiPath from $27.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, March 15th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $29.00 target price on shares of UiPath in a research report on Monday, April 1st. Nine research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, UiPath has a consensus rating of “Moderate Buy” and a consensus price target of $27.41.

UiPath Stock Performance

PATH stock opened at $19.89 on Thursday. The firm has a 50 day moving average price of $21.60 and a 200-day moving average price of $21.78. UiPath Inc. has a 52-week low of $13.30 and a 52-week high of $27.87. The firm has a market capitalization of $11.32 billion, a price-to-earnings ratio of -117.06 and a beta of 1.01.

UiPath (NYSE:PATH) last posted its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The firm had revenue of $405.25 million during the quarter, compared to analyst estimates of $383.32 million. As a group, sell-side analysts forecast that UiPath Inc. will post -0.04 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Ashim Gupta sold 40,000 shares of the company’s stock in a transaction on Thursday, April 4th. The stock was sold at an average price of $21.66, for a total transaction of $866,400.00. Following the transaction, the chief financial officer now directly owns 660,762 shares of the company’s stock, valued at $14,312,104.92. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders have sold a total of 96,000 shares of company stock worth $2,023,440 over the last 90 days. 31.03% of the stock is currently owned by insiders.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.